Alexander Selig

Alexander’s experience is focused on advising large and middle market buyout funds, and privately and publicly owned companies, in a wide variety of domestic and cross-border transactions and corporate processes across several industry sectors including financial services, technology, healthcare, and consumer and automotive products. 

Prior to joining Linklaters, Alexander was a senior associate at Allens, Linklaters' alliance firm, in Sydney.

Work highlights

• Hg alongside new and existing investors on new equity investment in Visma, valuing the business at US$21bn

• A consortium consisting of TDR Capital and I Squared Capital on their €1.26bn competing takeover offer for Applus Services S.A., a Spanish industrial testing company.

• Theramex (a portfolio company of Carlyle and PAI Partners) on its acquisition of certain rights and assets relating to the menopause therapy drugs Femoston and Duphaston from Viatris, Inc.

• KKR on its proposed bid for Ramsay Health Care Limited.*

• Pacific Equity Partners on: 

• its proposed (ultimately withdrawn) bid for Everlight Radiology;*
• the sale of Lifehealthcare to EBOS and related bolt-ons prior to sale; and*
• the sale of AutoPacific Group to GUD Holdings and related bolt-ons prior to sale.*

• Cerberus Capital on its acquisition of Westpac’s auto finance and strategic alliance businesses via its portfolio company, Angle Finance.*

*Matters handled prior to joining Linklaters.

Alexander is a board observer to Sundrop Farms, a leading horticultural player in Australia producing high-value fruit using renewable resources.

Alexander holds a Bachelor of Arts from the University of Sydney and a Juris Doctor from the University of New South Wales. 

Alexander is qualified in New South Wales, Australia.